Award
National Cancer Institute 1R21CA313790-01
Cross-species transfer learning for liquid biopsy-based cancer detection
Recipient
National Cancer Institute (NCI), part of the NIH
Award Amount
$402,068.00
Ceiling
$402,068.00
Awarded
May 04, 2026
Identifier
1R21CA313790-01
Award for developing a Raman spectroscopy-based liquid biopsy platform for early detection of rare cancers using cross-species data from canine models and human patients, funded by NIH/NCI.
Description
The project aims to develop a Raman spectroscopy-based liquid biopsy platform for early detection of rare cancers, leveraging cross-species data from canine models and human patients. The project is funded by NIH/NCI under grant PAR-25-139. The project duration is from May 4, 2026, to April 30, 2028.